This country profile provides an overview of South Africa’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
43%
Bilharzia
0%
River blindness
N/A
7.04 million people received treatment in South Africa in 2017 12.29 million people did not receive treatment in South Africa in 2017

Priorities for progress in South Africa

  • South Africa has the capacity and potential to provide treatment for bilharzia and intestinal worms.
  • It should work to develop a strategy to treat everyone, everywhere, in need of treatment and report in a timely manner to WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

South Africa does not require mass treatment for elephantiasis.

Blinding trachoma

South Africa does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 100% in 2016 to 43% in 2017.

Pre-sch and school-aged children needing treatment
16.41m
Pre-school and school-aged children receiving treatment
7.04m

Bilharzia

Treatment coverage remained the same at 0% in 2016 and 2017.

School-aged children needing treatment
2.58m
School-aged children receiving treatment
0m

River blindness

South Africa does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in South Africa.